P572-7701 Screening compound: 2-{5-[(3,4-dimethylphenyl)amino]-7-methyl-3-oxo-2H,3H-[1,2,4]triazolo[4,3-c]pyrimidin-2-yl}-N-ethyl-N-phenylacetamide

P572-7701 Screening compound: 2-{5-[(3,4-dimethylphenyl)amino]-7-methyl-3-oxo-2H,3H-[1,2,4]triazolo[4,3-c]pyrimidin-2-yl}-N-ethyl-N-phenylacetamide
P572-7701 Screening compound: 2-{5-[(3,4-dimethylphenyl)amino]-7-methyl-3-oxo-2H,3H-[1,2,4]triazolo[4,3-c]pyrimidin-2-yl}-N-ethyl-N-phenylacetamide alternative view

Chemical Structure Depiction of ChemDiv screening compound P572-7701
2-{5-[(3,4-dimethylphenyl)amino]-7-methyl-3-oxo-2H,3H-[1,2,4]triazolo[4,3-c]pyrimidin-2-yl}-N-ethyl-N-phenylacetamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

P572-7701

Molecular Formula

C24H26N6O2 (C24 H26 N6 O2)

Compound Name

2-{5-[(3,4-dimethylphenyl)amino]-7-methyl-3-oxo-2H,3H-[1,2,4]triazolo[4,3-c]pyrimidin-2-yl}-N-ethyl-N-phenylacetamide

IUPAC name

2-{5-[(34-dimethylphenyl)amino]-7-methyl-3-oxo-2H3H-[124]triazolo[43-c]pyrimidin-2-yl}-N-ethyl-N-phenylacetamide

SMILES

CCN(C(CN(C1=O)N=C2N1C(Nc1cc(C)c(C)cc1)=NC(C)=C2)=O)c1ccccc1

InChI

InChI=1S/C24H26N6O2/c1-5-28(20-9-7-6-8-10-20)22(31)15-29-24(32)30-21(27-29)14-18(4)25-23(30)26-19-12-11-16(2)17(3)13-19/h6-14H,5,15H2,1-4H3,(H,25,26)

InChI Key

VHHVWLDHRXYJSN-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27604618

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

430.51

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

7.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

4.080

Distribution Coefficient, logD

4.080

Water Solubility, LogSw

-4.05

Polar Surface Area

65.737

Acid Dissociation Constant (pKa)

11.06

Base Dissociation Constant (pKb)

3.47

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

25.00

P572-7701 in Drug Discovery

Included in Screening Libraries

C-Met Library (15277 compounds)

Serine Proteases Inhibitors Library (32732 compounds)

SmartTM Library (51161 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Endocrine
  • Infections
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Cardiovascular
  • Skin
  • Metabolic
  • Immune system
Targets:
  • Kinases
  • Proteases
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with P572-7701 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound P572-7701?
Check Price and Availability of P572-7701, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of P572-7701 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for P572-7701
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for P572-7701
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of P572-7701 available by request